Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Therapeutic Efficacy of Cutaneous Application of Postbiotic N-(1-carbamoyl-2-phenyl-ethyl) Butyramide (FBA) in Pediatric Subjects Affected by Atopic Dermatitis [NA]
This clinical-trial update reports on the therapeutic efficacy of a topical postbiotic, N-(1-carbamoyl-2-phenyl-ethyl) Butyramide (FBA), in …
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo [Phase 2]
A Phase 2 trial, sponsored by Sanofi, evaluates vaccine responses in adults with atopic dermatitis treated with subcutaneous amlitelimab ver…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD) [Phase 1]
Phase 1 clinical trial evaluating NM26-2198 in healthy subjects and patients with moderate-to-severe Atopic Dermatitis has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis [Phase 4]
Phase 4 study evaluating the long-term effect of dupilumab on skin barrier function in pediatric patients with atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Effects of an Emollient Containing Postbiotic Saccharomyces and Lactobacillus on Pediatric Atopic Dermatitis [NA]
A completed pediatric trial evaluated an emollient containing postbiotic Saccharomyces and Lactobacillus for atopic dermatitis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: A Study to Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety, pharmacokinetics, and preliminary efficacy of UCB9741 in healthy participants and in indiv…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: A Clinical Study to Evaluate SM17 in Healthy Participants [Phase 1]
Phase 1 trial evaluating SM17 in healthy participants has completed. The study lists Atopic Dermatitis, Asthma, and Inflammatory Bowel Disea…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Natural History of Severe Allergic Inflammation and Reactions
This update describes the completed observational study on the natural history of severe allergic inflammation across several rare immunoder…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis [Phase 2]
Phase 2b safety and efficacy study of CGB-500 topical ointment containing 0.5% and 1% tofacitinib for atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: A Study to Assess Efficacy and Safety of CGB-500, 1% Tofacitinib Versus an Active Comparator for Atopic Dermatitis [Phase 2]
A Phase 2 trial evaluated the efficacy and safety of CGB-500, a 1% topical tofacitinib, versus an active comparator for atopic dermatitis. T…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic Dermatitis [Phase 1]
Phase 1 clinical trial update for ENV-294 in healthy adults and adults with moderate-to-severe atopic dermatitis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SIM0718 in Adult and Adolescent Patients With Moderate to Severe Atopic Dermatitis [Phase 3]
A Phase 3 clinical trial evaluating SIM0718 for efficacy and safety in adults and adolescents with moderate to severe atopic dermatitis has …
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Role of Tyrosine Kinase Lyn and Cleaved Form by Caspases in Psoriasis [NA]
This clinical trial update discusses the role of Lyn tyrosine kinase and caspase-cleaved forms in psoriasis, with the study status listed as…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis [Phase 3]
Amgen reports completion of a Phase 3 trial evaluating self-administered rocatinlimab in adolescents and adults with moderate-to-severe atop…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis [Phase 1]
Phase 1 active-comparator safety study evaluating the combination of APG777 and APG990 for moderate-to-severe atopic dermatitis; the trial i…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2) [Phase 3]
This Phase 3 trial (COAST 2) evaluated subcutaneous amlitelimab monotherapy versus placebo in participants aged 12 and older with moderate-t…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Maternal Key Nutritional Factors and Offspring's Atopic Dermatitis (MKNFOAD)
A completed clinical trial update examining how maternal key nutritional factors influence the risk of offspring developing atopic dermatiti…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AK120 in Subjects With Moderate to Severe Atopic Dermatitis [Phase 2]
This clinical trial update notes the completion of a Phase 2 study evaluating the efficacy and safety of AK120 in adults with moderate to se…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: IDA (Immunothérapie de la Dermatite Atopique) Adult - Immunotherapy in Atopic Dermatitis [NA]
This update notes the completion of a clinical study of IDA immunotherapy for adults with atopic dermatitis. The trial was sponsored by INSE…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD [Phase 1]
Phase 1 trial of Soquelitinib in adults with moderate-to-severe atopic dermatitis shows safety and tolerability with preliminary signs of ef…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 2]
This document reports the completion status of a Phase 2 trial evaluating ATI-2138 in adults with moderate to severe atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: MYCobiome Analysis in Atopic Dermatitis With Head and Neck Involvement
The trial examining MYCobiome analysis in atopic dermatitis with head and neck involvement has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients [Phase 4]
Phase 4 clinical trial investigating whether decolonizing Staphylococcus aureus skin reduces disease severity in patients with atopic dermat…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic Eczema [Phase 4]
Phase 4 trial update evaluating the efficacy of crisaborole 2% cream versus placebo for mild-to-moderate atopic dermatitis (atopic eczema), …
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus [Phase 1]
This Phase 1 trial update reports on the safety, tolerability, and pharmacokinetics of ATTO-1310 in healthy volunteers and patients with ato…